Show All

Division Director

Andrew D. Hershey, MD, PhD, FAHS
Director, Division of Neurology

513-636-4222

andrew.hershey@cchmc.org

High Res

Andrew D. Hershey, MD, PhD, FAHS

Director, Division of Neurology

Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-3980

Email: andrew.hershey@cchmc.org

Show All

Specialties

Clinical Interests

Headaches; migraines; neurogenetics; neurometabolic disorders

Research Interests

Epidemiology; diagnostic criteria; treatment evaluation; outcome responses; quality of life issues; pharmaceutical trials; and neurogenetics of childhood headaches

Biography

Andrew Hershey, MD, PhD, FAHS, received his undergraduate degree at the University of Iowa, Iowa City, Iowa. He earned an honors degree in biochemistry; his research involved the enzyme kinetic properties of alcohol dehydrogenase in yeast.

After undergraduate school, Dr. Hershey attended the MD/PhD program at Washington University, St. Louis, Missouri. His PhD research thesis was entitled: "The Rat Substance P Receptor: cDNA and Genomic Cloning, Functional Expression, mRNA Distribution, and Mutational Analysis of Desensitization Responses."

After earning his MD and PhD, Dr. Hershey was an intern and resident in pediatrics at St. Louis Children's Hospital, St. Louis, MO. He then was an adult neurology resident at Barnes-Jewish Hospital, St. Louis, MO, followed by his child neurology fellowship at St. Louis Children's Hospital, St. Louis, MO.

After his fellowship, Dr. Hershey joined the faculty at Cincinnati Children's Hospital Medical Center, Ohio, where he is director of the Headache Center.

Dr. Hershey's research interests currently include the improved diagnosis and treatment of childhood headache disorders, characterization of outcome responses, studies in new pharmacological and non-pharmacological treatment regimes, and the neurogenetics of migraines.

Education and Training

BS: University of Iowa, Iowa City, IA, 1985.

MD: Washington University, St. Louis, MO, 1992.

PhD: Washington University, St. Louis, MO, 1992.

Residency: St. Louis Childrens Hospital, St. Louis, MO, 1993-1994; Barnes-Jewish Hospital, St. Louis, MO,1994-1995.

Fellowship: St. Louis Childrens Hospital, St. Louis, MO, 1995-1997.

Certification: Neurology with special competence in child neurology, 1998, recertified 2008; Headache Medicine, 2006.

Publications

View PubMed Publications

Hershey AD, Burdine D, Kabbouche MA, Powers SW. Genomic expression patterns in medication overuse headaches. Cephalalgia. 2011 Jan;31(2):161-71.

O'Brien HL, Kabbouche MA, Hershey AD. Treatment of acute migraine in the pediatric population. Curr Treat Options Neurol. 2010 May;12(3):178-85.

Hershey AD, Kabbouche MA, Powers SW. Treatment of pediatric and adolescent migraine. Pediatr Ann. 2010 Jul;39(7):416-23. doi: 10.3928/00904481-20100623-06. Review.

Wang X, Xiang J, Wang Y, Pardos M, Meng L, Huo X, Korostenskaja M, Powers SW, Kabbouche MA, Hershey AD. Identification of abnormal neuromagnetic signatures in the motor cortex of adolescent migraine. Headache. 2010 Jun;50(6):1005-16.

Hershey AD. Recent developments in pediatric headache. Curr Opin Neurol. 2010 Jun;23(3):249-53. Review.

Hershey AD. Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol. 2010 Feb;9(2):190-204. Review.

Slater S, Crawford MJ, Kabbouche MA, LeCates SL, Cherney S, Vaughan P, Segers A, Manning P, Burdine D, Powers SS, Hershey AD. Effects of gender and age on paediatric headache. Cephalalgia. 2009 Sep;29(9):969-73.

Khatri R, Hershey AD, Wong B. Prochlorperazine -- treatment for acute confusional migraine. Headache. 2009 Mar;49(3):477-80.

Hershey AD. Menstrual migraine: how early can it start? Headache. 2009 Mar;49(3):348-9. Crawford MJ, Lehman L, Slater S, Kabbouche MA, LeCates SL, Segers A, Manning P, Powers SW, Hershey AD.

Menstrual migraine in adolescents. Headache. 2009 Mar;49(3):341-7.

Residency Program Director

Donald L. Gilbert, MD, MS
Director, Movement Disorder Clinic and Tourette's Syndrome Clinic

513-636-4222

donald.gilbert@cchmc.org

High Res

Donald L. Gilbert, MD, MS

Director, Movement Disorder Clinic and Tourette's Syndrome Clinic

Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-3980

Email: donald.gilbert@cchmc.org

Show All

Specialties

Clinical Interests

Movement disorders; Tourette's Syndrome; Sydenham's Chorea; kernicterus; dystonia; ataxia; clinical research; transcranial magnetic stimulation

Research Interests

Clinical trials in Tourette's Syndrome and associated ADHD; epidemiology of Tourette's Syndrome and PANDAS; clinical effectiveness of multi-drug treatments in Tourette's Syndrome; transcranial magnetic stimulation in Tourette's Syndrome and pediatric movement disorders; functional neurosurgery for pediatric dystonia

Visit the Gilbert-Wu Lab.

Biography

Donald Gilbert, MD, earned his Bachelor of Arts at Princeton University, where he majored in philosophy. He subsequently earned his MD at the University of Michigan and spent a year at the National Institutes of Health as a Howard Hughes Medical Institute Research Scholar. Dr. Gilbert did his pediatrics and neurology training at John Hopkins in Baltimore and is board certified in neurology with special competence in child neurology. Dr. Gilbert has an MS in Clinical Research Design and Statistical Analysis from the University of Michigan.

At Cincinnati Children's, Dr. Gilbert directs the Movement Disorders and Tourette's Syndrome Clinics, which specialize in evaluation and pharmacologic treatment of tics, chorea, tremor, dystonia, stereotypies, ataxia, and other movement disorders. Dr. Gilbert directs or participates in a number of single and multi-center studies into causes and treatments of Tourette's Syndrome. Dr. Gilbert directs the Transcranial Magnetic Stimulation Laboratory at CCHMC.

Education and Training

BA: Princeton University, Princeton, NJ, 1987.

MD: University of Michigan School of Medicine, Ann Arbor, MI, 1993.

MS: University of Michigan, Ann Arbor, MI, 2003.

Residency: Johns Hopkins School of Medicine, Baltimore, MD, 1995.

Fellowship: Johns Hopkins School of Medicine, Baltimore, MD, 1995.

Certification: Board Certified in Neurology with Special Competence in Child Neurology, 2010. Board eligible in Pediatrics.

Appointment: Associate Professor of Pediatric Neurology.

Publications

View PubMed Publications

Ridel KR, Gilbert DL. Child neurology: past, present, and future: part 3: the future. Neurology. 2010 Oct 12;75(15):e62-4.

Wu SW, Harris E, Gilbert DL. Tic suppression: the medical model. J Child Adolesc Psychopharmacol. 2010 Aug;20(4):263-76.

Dalal P, Leslie ND, Lindor NM, Gilbert DL, Espay AJ. Motor tics, stereotypies, and self-flagellation in primrose syndrome. Neurology. 2010 Jul 20;75(3):284-6.

Ridel KR, Lipps TD, Gilbert DL. The prevalence of neuropsychiatric disorders in Sydenham's chorea. Pediatr Neurol. 2010 Apr;42(4):243-8.

Hopkins SE, Somoza A, Gilbert DL. Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease. J Child Neurol. 2010 Jun;25(6):752-6.

Degrauw RS, Li JZ, Gilbert DL. Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome. Pediatr Neurol. 2009 Sep;41(3):183-6.

Gilbert DL. Acute and chronic chorea in childhood. Semin Pediatr Neurol. 2009 Jun;16(2):71-6. Review.

Wong B, Gilbert DL, Walker WL, Liao IH, Lit L, Stamova B, Jickling G, Apperson M, Sharp FR. Gene expression in blood of subjects with Duchenne muscular dystrophy. Neurogenetics. 2009 Apr;10(2):117-25.

Gilbert DL, Leslie EJ, Keddache M, Leslie ND. A novel hereditary spastic paraplegia with dystonia linked to chromosome 2q24-2q31. Mov Disord. 2009 Feb 15;24(3):364-70.

Gilbert DL. Drug-induced movement disorders in children. Ann N Y Acad Sci. 2008 Oct;1142:72-84. Review.

Faculty

Todd M. Arthur, MD
Pediatric Epileptologist

513-636-4222

Jim Collins is an Assistant Professor and Attending Physician at Cincinnati Children's.

James (Jim) J. Collins, MD, PhD
Assistant Professor of Child Neurology

513-636-4222

james.collins@cchmc.org

High Res

Jim J. Collins, MD, PhD

Assistant Professor of Child Neurology

Assistant Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-1888

Email: james.collins@cchmc.org

Show All

Specialties

Congenital muscular dystrophies; merosin-deficient congenital muscular dystrophy

Biography

James Collins MD, PhD obtained specialty training in Neuromuscular disorders at the Institute of Human Genetics, Centre for Life, University of Newcastle, Newcastle, UK, in the last months of his residency training. He was then appointed Assistant Professor at Cincinnati Children’s Hospital Medical Center where he follows patients in general Neurology and in the Comprehensive Neuromuscular Center.

Education and Training

PhD: Kent State University, Kent, OH 2000.

MD: University of Cincinnati, Cincinnati, OH 2004.

Residency: Pediatric Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 2009.

Certification: Child Neurology, 2009.

Publications

View PubMed Publications

Collins J and Bönneman CG. Congenital Muscular Dystrophies: Toward Molecular Therapeutic Intervention. Current Neurology and Neuroscience Reports. 2010 Mar;10(2):83-91.

Collins J, Tang LY, Dimmock D, Morehart P, Bove K, Wong LJC, Wong B. Progressive myofiber changes of a childhood mitochondrial DNA depletion syndrome with a novel Thymidine Kinase 2 gene mutation. Neuromuscul Disord. 2009;19:784-787.

David Neal Franz, MD
Director, Tuberous Sclerosis Clinic

513-636-4222

franz@cchmc.org

High Res

David Neal Franz, MD

Director, Tuberous Sclerosis Clinic

Associate Director of Clinical Affairs, Division of Neurology

Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-1888

Email: franz@cchmc.org

Show All

Specialties

Tuberous sclerosis (adults and children); neuropharmacology; neurocutaneous disorders; general pediatric neurology

Biography

David Neal Franz, MD, was born and raised in Dayton, Ohio. He received his undergraduate degree in History and Literature from Earlham College in Richmond, Indiana.

After completing his training, he served as Assistant Professor of Neurology and Pediatrics at Wright State University before returning to Cincinnati Children's Hospital Medical Center.

He established the Cincinnati Tuberous Sclerosis Clinic in 1993, to assist in the medical care of patients who have or are suspected of having tuberous sclerosis. The purpose of the clinic is not to replace care from the child's pediatrician or family physician, but to assist the primary care physician in dealing with those aspects unique to tuberous sclerosis that affect the child's health or development. The basis of the clinic is the realization that people with tuberous sclerosis are different from other individuals who have epilepsy, learning disabilities, behavior problems, etc.

For too long, the unique problems found in this disease have been lumped together with similar disorders, despite the fact that research has shown that disorders of the brain, heart, kidney, and other organs in tuberous sclerosis are quite different.

Education and Training

MD: Ohio State University College of Medicine, Columbus, OH, 1985.

Residency: Wright State University Affiliated Hospitals, Dayton, OH.

Fellowship: Children's Hospital Medical Center, Cincinnati, OH.

Certification: Pediatrics, 1990; Neurology with special competence in child neurology, 1992.

Publications

View PubMed Publications

Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics. 2010 Oct;41(5):199-208.

Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, Wilson KA, Byars A, Sahmoud T, Franz DN. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010 Nov 4;363(19):1801-11.

Young LR, Vandyke R, Gulleman PM, Inoue Y, Brown KK, Schmidt LS, Linehan WM, Hajjar F, Kinder BW, Trapnell BC, Bissler JJ, Franz DN, McCormack FX. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest. 2010 Sep;138(3):674-81.

Young LR, Franz DN, Nagarkatte P, Fletcher CD, Wikenheiser-Brokamp KA, Galsky MD, Corbridge TC, Lam AP, Gelfand MJ, McCormack FX. Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis. Chest. 2009 Sep;136(3):926-33.

Schmithorst VJ, Altes TA, Young LR, Franz DN, Bissler JJ, McCormack FX, Dardzinski BJ, Brody AS. Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis. AJR Am J Roentgenol. 2009 Apr;192(4):1037-44.

Krueger DA, Franz DN. Current management of tuberous sclerosis complex. Paediatr Drugs. 2008;10(5):299-313. Review.

Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, Schmithorst VJ, Laor T, Brody AS, Bean J, Salisbury S, Franz DN. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008 Jan 10;358(2):140-51.

Levine NB, Collins J, Franz DN, Crone KR. Gradual formation of an operative corridor by balloon dilation for resection of subependymal giant cell astrocytomas in children with tuberous sclerosis: specialized minimal access technique of balloon dilation. Minim Invasive Neurosurg. 2006 Oct;49(5):317-20.

Collins JJ, Tudor C, Leonard JM, Chuck G, Franz DN. Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. J Child Neurol. 2006 Jan;21(1):53-7.

Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol. 2006 Mar;59(3):490-8.

Donald L. Gilbert, MD, MS
Director, Movement Disorder Clinic and Tourette's Syndrome Clinic

513-636-4222

donald.gilbert@cchmc.org

High Res

Donald L. Gilbert, MD, MS

Director, Movement Disorder Clinic and Tourette's Syndrome Clinic

Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-3980

Email: donald.gilbert@cchmc.org

Show All

Specialties

Clinical Interests

Movement disorders; Tourette's Syndrome; Sydenham's Chorea; kernicterus; dystonia; ataxia; clinical research; transcranial magnetic stimulation

Research Interests

Visit the Gilbert-Wu Lab.

Biography

Education and Training

Publications

View PubMed Publications

Ridel KR, Gilbert DL. Child neurology: past, present, and future: part 3: the future. Neurology. 2010 Oct 12;75(15):e62-4.

Ridel KR, Lipps TD, Gilbert DL. The prevalence of neuropsychiatric disorders in Sydenham's chorea. Pediatr Neurol. 2010 Apr;42(4):243-8.

Degrauw RS, Li JZ, Gilbert DL. Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome. Pediatr Neurol. 2009 Sep;41(3):183-6.

Gilbert DL. Acute and chronic chorea in childhood. Semin Pediatr Neurol. 2009 Jun;16(2):71-6. Review.

Gilbert DL, Leslie EJ, Keddache M, Leslie ND. A novel hereditary spastic paraplegia with dystonia linked to chromosome 2q24-2q31. Mov Disord. 2009 Feb 15;24(3):364-70.

Gilbert DL. Drug-induced movement disorders in children. Ann N Y Acad Sci. 2008 Oct;1142:72-84. Review.

Tracy A. Glauser, MD
Director, Comprehensive Epilepsy Center

513-636-4222

tracy.glauser@cchmc.org

High Res

Tracy A. Glauser, MD

Director, Comprehensive Epilepsy Center

Co-Director, Genetic Pharmacology Service

Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-3980

Email: tracy.glauser@cchmc.org

Show All

Specialties

Clinical Interests

Epilepsy; pharmacogenetics; clinical pharmacology

Research Interests

Clinical pharmacology; pharmacogenetics; antiepileptic clinical trials

Biography

Tracy A. Glauser, MD, is professor of Pediatrics, director of the Comprehensive Epilepsy Center and co-director of the Genetic Pharmacology Service at Cincinnati Children’s Hospital Medical Center. Dr. Glauser received his medical degree, cum laude, from Jefferson Medical College in Philadelphia, PA. He completed his residency in pediatrics at the John Hopkins Hospital in Baltimore, MD, and fellowship in child neurology at The Children’s Hospital of Philadelphia, University of Pennsylvania in Philadelphia, PA. Dr. Glauser completed a National Institute of Neurological Disorders and Stroke research fellowship in pediatric neurology and was a fellow in epilepsy and electroencephalography at St. Louis Children’s Hospital, Washington University School of Medicine in St. Louis, Missouri.

Dr. Glauser has authored and co-authored more than 130 articles and book chapters, been involved with the development of 6 evidence based guidelines about epilepsy therapy and given over 150 invited lectures throughout the world. He has been the principal investigator on multiple NIH grants. Currently, Dr. Glauser directs the NIH funded Childhood Absence Epilepsy clinical trial involving 32 pediatric centers around the United States. Dr. Glauser’s fields of expertise are pediatric neurology, pediatric epilepsy, clinical pharmacology and pharmacogenetics.

Education and Training

MD: Jefferson Medical College, Philadelphia, PA, 1985.

Residency: Johns Hopkins Hospital, Baltimore, MD.

Fellowship: St. Louis Children's Hospital, St. Louis, MO.

Certification: Pediatrics, 1990; Neurology (with special competence in child neurology), 1991.

Publications

View PubMed Publications

Modi AC, Guilfoyle SM, Morita DA, Glauser TA. Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy. Epilepsia. 2010 Nov 18. doi: 10.1111/j.1528-1167.2010.02789.x.

Modi AC, Monahan S, Daniels D, Glauser TA. Development and validation of the Pediatric Epilepsy Medication Self-Management Questionnaire. Epilepsy Behav. 2010 May;18(1-2):94-9

Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Capparelli EV, Adamson PC; Childhood Absence Epilepsy Study Group. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. 2010 Mar 4;362(9):790-9.

Holland KD, Monahan S, Morita D, Vartzelis G, Glauser TA. Valproate in children with newly diagnosed idiopathic generalized epilepsy. Acta Neurol Scand. 2010 Mar;121(3):149-53.

Pestian J, Spencer M, Matykiewicz P, Zhang K, Vinks AA, Glauser T. Personalizing Drug Selection Using Advanced Clinical Decision Support. Biomed Inform Insights. 2009 Jun 23;2:19-29.

Prows CA, Nick TG, Saldaña SN, Pathak S, Liu C, Zhang K, Daniels ZS, Vinks AA, Glauser TA. Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients. J Child Adolesc Psychopharmacol. 2009 Aug;19(4):385-94.

Modi AC, King AS, Monahan SR, Koumoutsos JE, Morita DA, Glauser TA. Even a single seizure negatively impacts pediatric health-related quality of life. Epilepsia. 2009 Sep;50(9):2110-6.

Daniels ZS, Nick TG, Liu C, Cassedy A, Glauser TA. Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy. Neurology. 2009 Sep 1;73(9):658-64.

Glauser TA, Sankar R; Co-chairs of the Leadership in Epilepsy, Advocacy, and Development Faculty. Core elements of epilepsy diagnosis and management: expert consensus from the Leadership in Epilepsy, Advocacy, and Development (LEAD) faculty. Curr Med Res Opin. 2008 Dec;24(12):3463-77.

Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008 May 20;70(21):1950-8.

Grants

Sodium channel gene variation in the treatment of epilepsy. Collaborator. Apr 2009 - Mar 2014. #R01NS062756.

The epilepsy phenome/ genome project (EPGP). Pharmacogenetics Core/Site Principal Investigator. May 2007- Apr 2012. #R01NS053998.

Barbara E. Hallinan, MD, PhD
Pediatric Neurologist

513-636-4222

Andrew D. Hershey, MD, PhD, FAHS
Director, Division of Neurology

513-636-4222

andrew.hershey@cchmc.org

High Res

Andrew D. Hershey, MD, PhD, FAHS

Director, Division of Neurology

Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-3980

Email: andrew.hershey@cchmc.org

Show All

Specialties

Clinical Interests

Headaches; migraines; neurogenetics; neurometabolic disorders

Research Interests

Epidemiology; diagnostic criteria; treatment evaluation; outcome responses; quality of life issues; pharmaceutical trials; and neurogenetics of childhood headaches

Biography

After his fellowship, Dr. Hershey joined the faculty at Cincinnati Children's Hospital Medical Center, Ohio, where he is director of the Headache Center.

Education and Training

Publications

View PubMed Publications

Hershey AD, Burdine D, Kabbouche MA, Powers SW. Genomic expression patterns in medication overuse headaches. Cephalalgia. 2011 Jan;31(2):161-71.

O'Brien HL, Kabbouche MA, Hershey AD. Treatment of acute migraine in the pediatric population. Curr Treat Options Neurol. 2010 May;12(3):178-85.

Hershey AD, Kabbouche MA, Powers SW. Treatment of pediatric and adolescent migraine. Pediatr Ann. 2010 Jul;39(7):416-23. doi: 10.3928/00904481-20100623-06. Review.

Hershey AD. Recent developments in pediatric headache. Curr Opin Neurol. 2010 Jun;23(3):249-53. Review.

Hershey AD. Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol. 2010 Feb;9(2):190-204. Review.

Katherine D. Holland-Bouley, MD, PhD
Pediatric Epileptologist

katherine.holland@cchmc.org

High Res

Katherine D. Holland-Bouley, MD, PhD

Pediatric Epileptologist

Assistant Professor, UC Department of Pediatrics

Email: katherine.holland@cchmc.org

Show All

Specialties

Mechanisms of epileptogenesis

Education and Training

MD: Washington University, St Louis MO, 1991.

PhD (pharmacology): Washington University, St Louis MO, 1991.

Internship: Children's Hospital, Boston MA.

Residency: St Louis Children's Hospital, St Louis, MO.

Certification: Neurology with added qualification in pediatric neurology, 2000.

Publications

View PubMed Publications

Standridge SM, Holland KD, Horn PS. Cardiac arrhythmias and ictal events within an epilepsy monitoring unit. Pediatr Neurol. 2010 Mar;42(3):201-5.

Holland KD, Monahan S, Morita D, Vartzelis G, Glauser TA. Valproate in children with newly diagnosed idiopathic generalized epilepsy. Acta Neurol Scand. 2010 Mar;121(3):149-53.

Holland KD, Kearney JA, Glauser TA, Buck G, Keddache M, Blankston JR, Glaaser IW, Kass RS, Meisler MH. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. Neurosci Lett. 2008 Mar 5;433(1):65-70.

Holland KD, Glauser TA. Response to carbamazepine in children with newly diagnosed partial onset epilepsy. Neurology. 2007 Aug 7;69(6):596-9.

Holland KD, Fleming MT, Cheek S, Moran JL, Beier DR, Meisler MH. De novo exon duplication in a new allele of mouse Glra1 (spasmodic). Genetics. 2006 Dec;174(4):2245-7.

Sejal V. Jain, MD
Director, Epilepsy-Sleep Clinical Program

513-636-4222

sejal.jain@cchmc.org

Sejal V. Jain, MD

Director, Epilepsy-Sleep Clinical Program

Director, Epilepsy/Clinical Neurophysiology Fellowship Program

Pediatric Epileptologist

Assistant Professor, UC Department of Pediatrics

Phone: 513-636-4222

Email: sejal.jain@cchmc.org

Show All

Specialties

Clinical Interests

Medical and surgical management of epilepsy; sleep disorders

Research Interests

Sleep disorders in children with epilepsy; clinical drug trials

Biography

Dr. Jain is a clinical researcher who is trained in pediatric epilepsy and sleep medicine. Her clinical research is focused on sleep disorders in children with epilepsy. The core of her research is to identify the best treatment options for sleep disorders in children with epilepsy and evaluate the impact on seizure control. Dr. Jain is also interested in antiepileptic drug trials.

Dr. Jain developed and is currently directing the Epilepsy-Sleep Clinical Program. She also directs the Epilepsy/Clinical Neurophysiology Fellowship Program. She is ranked among America’s top physicians (Consumer Research Council of America, 2009-2012).

Education and Training

MD: Gujarat University, India.

Residency: Nassau University Medical Center, NY.

Fellowships: Clinical Neurophysiology and Pediatric Neurology, Virginia Commonwealth University, Richmond, Virginia; Sleep Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Certifications: Neurology (Child Neurology); Clinical Neurophysiology, Sleep Medicine.

Publications

View PubMed Publications

Jain SV, Simakajornboon N, Glauser, TA. Provider practices impact adequate diagnosis of sleep disorders in children with epilepsy. J Child Neurol. 2013 May;28(5):589-95.

Natarajan, N, Jain SV, Chaudhry H, Hallinan BE, Simakajornboon N. Narcolepsy-cataplexy: is streptococcal infection a trigger? J Clin Sleep Med. 2013 Mar 15;9(3):269-70.

Jain SV, Horn PS, Simakajornboon N, Glauser, TA. Obstructive sleep apnea and primary snoring in children with epilepsy. J Child Neurol. 2013 Jan;28(1):77-82.

Jain SV, Simakajornboon N, Arthur TM. Central sleep apnea: does stabilizing sleep improve it?J Child Neurol. 2012 Dec 5. [Epub ahead of print]

Fujiwara H, Greiner HM, Hemasilpin N, Lee KH, Holland-Bouley K, Arthur T, Morita D, Jain SV, Mangano FT, Degrauw T, Rose DF. Ictal MEG onset source localization compared to intracranial EEG and outcome: improved epilepsy presurgical evaluation in pediatrics. Epilepsy Res. 2012 May;99(3):214-24.

Jain SV, Simakajornboon S, Shapiro SM, Morton LD, Leszczyszyn DJ, Simakajornboon N. Obstructive sleep apnea in children with epilepsy: prospective pilot trial. Acta Neurol Scand. 2012 Jan;125(1):e3-6.

Jain SV, Kothare SV. Should we be targeting the sleep-wake patterns of children with epilepsy? Neuropsychiatry. 2011;1(6), 517–520.

Book Chapters

Jain SV. Sleep Terrors and Confusional Arousals in Children and Adolescent. In Kothare SV and Ivanenko A. Prasomnia: Clinical Characteristics and Treatment. Springer (in press).

Arya R, Jain SV. Sleep Walking in Children and Adolescent. In Kothare SV and Ivanenko A. Prasomnia: Clinical Characteristics and Treatment. Springer (in press).

Jain SV, Morton LD. Evaluating the Child with Seizure: In Pellock JM, Dodson EW, Bourgeois BF, and Nordlii DR: Pediatric Epilepsy, Diagnosis and Treatment. New York, Demos Medical Publishing: Nov 2007.

Grants

Clinical Research Feasibility Funds (CReFF). Principle Investigator. Center for Clinical and Translational Science and Training, Cincinnati Children’s Hospital Medical Center. Apr 2010 - Jul 2013.

Clinical and Translational Science Award (CTSA). Principle Investigator. The National Center for Research Resources, NIH. Jul 2010 - Jul 2013. USPHS Grant # UL1RR026314.

Marielle A. Kabbouche, MD
Child Neurologist

513-636-4222

marielle.kabbouche@cchmc.org

High Res

Marielle A. Kabbouche, MD

Child Neurologist

Associate Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-1888

Email: marielle.kabbouche@cchmc.org

Show All

Specialties

Clinical Interests

Headaches; migraines; acute and inpatient treatment of intractable headache

Research Interests

Headache; outcome studies; health improvement; clinical effectiveness

Biography

Marielle Kabbouche, MD, received her training in Child Neurology at Vanderbilt University school of medicine. She moved to Cincinnati for a specialty training in pediatric headache medicine . The position was the first for a pediatric neurologist.

After her headache training she stayed at Cincinnati Children's as faculty and active member of the center with involvement in all academic as well as clinical and teaching aspect of pediatric headache. Since that time she has been proud to be part of the maturing center that gradually developed to be the largest and most academically productive pediatric headache program in the United States and worldwide. She has been a co- PI on multiple NIH grants since 2002 and have been involved in multiple pharmaceutical and clinical studies in pediatric and adolescent migraine.

Her carrier has been focused on acute treatment of intractable Migraine in Children in emergency room as well as inpatient settings.

As the Director of the inpatient headache unit, Dr. Kabbouche was actively involved in setting an acute headache infusion center as well as an inpatient headache unit at Cincinnati Children’s Hospital Medical Center. The Headache acute care unit has been very productive in the last few years and seeing about 200-300 patients/year during peak seasons. The inpatient unit will open in July of 2011 bringing specialty care to the headache patients with a team of 6 providers , fellows , residents and nurses. This approach to intractable headache care will have a great impact on patient’s outcome.

Dr. Kabbouche has over 25 publications, and a track record of numerous peer-reviewed papers, reviews, and abstracts in the field of headache medicine, book chapters as well as being an editor of a pediatric headache book.

Education and Training

MD: Saint Joseph University, Faculty of Medicine, Beirut, Lebanon.

Residency: Vanderbilt University Medical Center, Nashville, TN.

Fellowship: Cincinnati Children's Hospital, Cincinnati, OH.

Publications

View PubMed Publications

Hershey AD, Kabbouche MA, Powers SW. Treatment of pediatric and adolescent migraine. Pediatr Ann. 2010 Jul;39(7):416-23.

Kabbouche MA, Cleves C. Evaluation and management of children and adolescents presenting with an acute setting. Semin Pediatr Neurol. 2010 Jun;17(2):105-8.

Kabbouche MA, Powers SW, Segers A, LeCates S, Manning P, Biederman S, Vaughan P, Burdine D, Hershey AD. Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache. 2009 Jan;49(1):106-9.

Kabbouche MA, Gilman DK. Management of migraine in adolescents. Neuropsychiatr Dis Treat. 2008 Jun;4(3):535-48.

Kabbouche MA, Linder SL. Management of migraine in children and adolescents in the emergency department and inpatient setting. Curr Pain Headache Rep. 2005 Oct;9(5):363-7.

Kabbouche MA, Linder SL. Acute treatment of pediatric headache in the emergency department and inpatient settings. Pediatr Ann. 2005 Jun;34(6):466-71.

Kabbouche MA, Powers SW, Vockell ALB, LeCates SL, Ellinor PL, Segers A, Manning P, Hershey AD. Outcome of a multidisciplinary approach of pediatric migraine at 1, 2, and 5 years. Headache. 2005;45:1298-1303.

Book Chapters

Kabbouche MA. Migraine variants. In Andrew Hershey, Scott Powers, Paul Winners and Marielle Kabbouche (Eds.) Pediatric Headache in Clinical Practice. Wiley Blackwell, 2009.

Kabbouche MA. Other primary headaches. In Andrew Hershey, Scott Powers, Paul Winners and Marielle Kabbouche (Eds.) Pediatric Headache in Clinical Practice. Wiley Blackwell, 2009.

Kabbouche MA. Emergent therapy for children and adolescent. In Andrew Hershey, Scott Powers, Paul Winners and Marielle Kabbouche (Eds.) Pediatric Headache in Clinical Practice. Wiley Blackwell, 2009.

Grants

Acute treatment of headaches in children and adolescents. Co-Principal Investigator. American Headache Society. 2007 - 2012.

Drug & Non-Drug Treatment of Pediatric Chronic Headache. Co-Investigator. National Institute of Neurological Disorders and Stroke. 2006 - 2011. #R01 NS050536-01A1.

Darcy A. Krueger, MD, PhD
Associate Director of Research, Division of Neurology

513-636-4222

krueger_darcy@cchmc.org

Michael V. Miles, PharmD
Director, Neuropharmacology Laboratory

513-636-7871

michael.miles@cchmc.org

High Res

Michael V. Miles, PharmD

Director, Neuropharmacology Laboratory

Professor, UC Department of Pediatrics

Phone: 513-636-7871

Fax: 513-636-1888

Email: michael.miles@cchmc.org

Show All

Specialties

Pediatric pharmacology; laboratory tests and biomarkers for monitoring mitochondrial function and oxidative stress; mitochondrial abnormalities associated with aging, obesity, sleep apnea, epilepsy and nutritional deficiencies; safety and efficacy of treatment with antioxidants, such as coenzyme Q and vitamin E.

Biography

Michael V. Miles, PharmD, has been a member of the Division of Pediatric Neurology for over 5 years. He is an experienced clinician and researcher, who has studied the pharmacokinetics and pharmacodynamics of drugs in pediatric populations for much of his career. He has dedicated his clinical and research efforts to improving the efficacy and safety of drug therapy for infants and children. His research is currently focused on the development of new biomarkers and therapeutic agents for patients with mitochondrial diseases.

Education and Training

PharmD: University of Texas at Austin, Austin, Texas, 1979.

Specialty Residency: Pediatric Clinical Pharmacy, University of Texas at Austin, Austin, Texas.

Certification: Pharmacy, 1976.

Publications

View PubMed Publications

Miles MV, Putnam PE, Miles L, Tang PH, DeGrauw AJ, Wong BL, Horn PS, Foote HL, Rothenberg ME. Acquired coenzyme Q10 deficiency in children with recurrent food intolerance and allergies. Mitochondrion. 2011 Jan;11(1):127-35.

Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology. 2010 Sep;52(3):934-44.

Miles MV, Tang PH, Miles L, Steele PE, Moye MJ, Horn PS. Validation and application of an HPLC-EC method for analysis of coenzyme Q10 in blood platelets. Biomed Chromatogr. 2008 Dec;22(12):1403-8.

Miles MV, Miles L, Tang PH, Horn PS, Steele PE, DeGrauw AJ, Wong BL, Bove KE. Systematic evaluation of muscle coenzyme Q10 content in children with mitochondrial respiratory chain enzyme deficiencies. Mitochondrion. 2008 Mar;8(2):170-80.

Miles MV, Patterson BJ, Chalfonte-Evans ML, Horn PS, Hickey FJ, Schapiro MB, Steele PE, Tang PH, Hotze SL. Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21. Pediatr Neurol. 2007 Dec;37(6):398-403.

Miles MV. The uptake and distribution of coenzyme Q10. Mitochondrion. 2007 Jun;7 Suppl:S72-7.

Tang PH, Miles MV, Steele P, Davidson BS, Geraghty SR, Morrow AL. Determination of coenzyme Q10 in human breast milk by high-performance liquid chromatography. Biomed Chromatogr. 2006 Dec;20(12):1336-43.

Miles MV, Patterson BJ, Schapiro MB, Hickey FJ, Chalfonte-Evans M, Horn PS, Hotze SL. Coenzyme Q10 absorption and tolerance in children with Down syndrome: a dose-ranging trial. Pediatr Neurol. 2006 Jul;35(1):30-7.

Miles L, Miles MV, Tang PH, Horn PS, Quinlan JG, Wong B, Wenisch A, Bove KE. Ubiquinol: a potential biomarker for tissue energy requirements and oxidative stress. Clin Chim Acta. 2005 Oct;360(1-2):87-96.

Miles L, Miles MV, Tang PH, Horn PS, Wong BL, DeGrauw TJ, Morehart PJ, Bove KE. Muscle coenzyme Q: a potential test for mitochondrial activity and redox status. Pediatr Neurol. 2005 May;32(5):318-24.

Diego A. Morita, MD
Co-Director, New Onset Seizure Clinic

513-636-4222

diego.morita@cchmc.org

High Res

Diego A. Morita, MD

Co-Director, New Onset Seizure Clinic

Assistant Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-1888

Email: diego.morita@cchmc.org

Show All

Specialties

Clinical Interests

Epilepsy; therapeutic drug management; pharmacogenetics

Research Interests

Clinical pharmacology; population pharmacokinetics; antiepileptic drug tolerability

Biography

Dr. Morita obtained his Medical Degree with honors from the University of Buenos Aires School of Medicine in Buenos Aires, Argentina. He finished a three-year residency in Pediatrics at Buenos Aires British Hospital in Buenos Aires, Argentina. In 1996, he came to the United States and continued his training in Pediatrics at Miami Children's Hospital in Miami, Florida.

Dr. Morita was then a resident in Neurology at the University of Cincinnati, and later a fellow in Child Neurology at Cincinnati Children's. He completed fellowship training in Clinical Neurophysiology and Epilepsy, and Epilepsy Clinical Neuropharmacology, both at Cincinnati Children's.

After his fellowships, Dr. Morita opened a Child Neurology private practice in Buenos Aires, Argentina, and in 2005 returned and joined the faculty at Cincinnati Children's.

Dr. Morita's interests currently include the objective assessment of antiepileptic drug side effects, pharmacogenetics of antiepileptic drugs, and individualization of drug therapy.

Education and Training

MD: University of Buenos Aires, Buenos Aires, Argentina, 1992.

Residency: Buenos Aires British Hospital, Buenos Aires, Argentina; Miami Children's Hospital, Miami, FL; University of Cincinnati, Cincinnati, OH.

Fellowship: Child Neurology: Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Clinical Neurophysiology and Epilepsy: Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Epilepsy Clinical Neuropharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Publications

View PubMed Publications

Holland KD, Monahan S, Morita D, Vartzelis G, Glauser TA. Valproate in children with newly diagnosed idiopathic generalized epilepsy. Acta Neurol Scand. 2010 Mar;121(3):149-53.

Modi AC, King AS, Monahan SR, Koumoutsos JE, Morita DA, Glauser TA. Even a single seizure negatively impacts pediatric health-related quality of life. Epilepsia. 2009 Sep;50(9):2110-6.

Modi AC, Morita DA, Glauser TA. One-month adherence in children with new-onset epilepsy: white-coat compliance does not occur. Pediatrics. 2008 Apr;121(4):e961-6.

Douglas F. Rose, MD
Pediatric Epileptologist

513-636-4222

douglas.rose@cchmc.org

High Res

Douglas F. Rose, MD

Pediatric Epileptologist

Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-3980

Email: douglas.rose@cchmc.org

Show All

Specialties

Clinical Interests

Epilepsy; improvement of the quality of life for children with epilepsy; studies of brain and physiology to better understand brain function

Research Interests

Neuropharmacology; epilepsy surgery; central auditory processing; magnetoencephalography; functional cortical mapping; fMRI; SPECT; vagus nerve stimulator; ketogenic diet; language development and language disorders

Biography

Dr. Rose grew up in Cleveland, Ohio. He and his wife lived briefly in Fairborn and Dayton, Ohio when first married. Subsequently they moved to Washington, DC to study and work at the National Institutes of Health. They then moved to Albuquerque, New Mexico for several years to continue work and research, before moving to Memphis, Tennessee and then Cincinnati.

Education and Training

MD: Case Western Reserve University, Cleveland, Ohio, 1977

Residency: Rainbow Babies and Childrens, Cleveland, Ohio, 1979

Fellowship: University Hospitals, Cleveland, Ohio, 1982

Instructor:, Department of Neurology, University Hospitals, Cleveland, Ohio, 1983

Fellowship: Epilepsy, National Institutes of Health, Bethesda, Md., 1983-1984

Fellowship: Neurophysiology, National Institutes of Health, Bethesda, Md., 1984-1985

Medical Staff Fellow: Clinical Epilepsy Section, National Institutes of Health, 1983-1984

Medical Staff Fellow: EEG Laboratory, National Institutes of Health, 1984-1986

Medical Staff Fellow: Unit on Neurophysiology, National Institutes of Health, 1986-1987

Senior Staff Fellow: Unit on Neurophysiology, National Institutes of Health, 1987-1989

Associate Professor: Department of Neurology, University of New Mexico, Albuquerque, N.M., 1989-1992

Director: Center for Magnetoencephalography, Albuquerque, N.M., 1989-1992

Associate Professor: Department of Pediatrics, University of Tennessee, Memphis, Tenn. 1992-2000

Associate Professor: Department of Neurology, University of Tennessee, Memphis, Tenn. 1992-2000

Adjunct Associate Professor: Memphis Speech and Hearing Center, Department of Audiology, University of Memphis, Tenn., 1998-present.

Division Chief: Child Neurology, Department of Pediatrics, University of Tennessee, 1994-2000

Medical Director: Comprehensive Epilepsy Center, Le Bonheur Children's Medical, Center, Memphis, Tenn., 1992-2000

Director: Cincinnati Children's Neurodiagnostic Laboratory, 2003 to present.

Director: Cincinnati Children's Clinical Neurophysiology Fellowship Program, 2001 to present.

Medical Director: Cincinnati Children's MEG Center, 2005 to present.

Certification: Pediatrics 1984 ; Neurology with special competence in Child Neurology 1984; Clinical Neurophysiology 1986; Added Qualifications in Clinical Neurophysiology 1994

Practice Locations: Cincinnati Children's Hospital Medical Center Main Campus; Outpatient Services -- Anderson

Irina Rybalsky, MD, PhD
Staff Physician

513-636-4222

irina.rybalsky@cchmc.org

Mark Schapiro, MD

513-636-4222

mark.schapiro@cchmc.org

Shannon M. Standridge, MPH, DO

513-636-4222

neurodesk@cchmc.org

Mary Sutton, MD

513-636-4222

Jennifer J. Vannest, PhD

513-636-6959

jennifer.vannest@cchmc.org

High Res

Jennifer J. Vannest, PhD

Assistant Professor, UC Department of Pediatrics

Phone: 513-636-6959

Email: jennifer.vannest@cchmc.org

Show All

Specialties

Clinical Interests

Cognitive neuroscience of language and memory (using functional MRI); cognitive effects of epilepsy and neurodevelopmental disorders

Research Interests

Neurological disorders and language impairments

Biography

Jennifer Vannest, PhD, completed her undergraduate education at the Ohio State University and continued there for her graduate work. Her PhD is in Linguistics, and in addition, her graduate training included a number of courses in Cognitive Psychology, Neuropsychology and Speech and Hearing Sciences. As a postdoctoral fellow at University of Michigan and University of Rochester, Dr. Vannest was trained to use functional MRI to study the brain mechanisms underlying language skill.

Dr. Vannest came to Cincinnati Children's Hospital Medical Center in 2006, and her current research makes use of functional MRI to examine how epilepsy and neurodevelopmental disorders affect language function, ultimately leading to better treatment and educational strategies for children with these disorders.

Education and Training

PhD: Ohio State University, Linguistics.

Postdoctoral Training: University of Michigan (Psychology), University of Rochester (Brain and Cognitive Sciences).

Publications

View PubMed Publications

Vannest J, Newport EL, Newman AJ, Bavelier D. Interplay between morphology and frequency in lexical access: The case of the base frequency effect. Brain Res. 2011 Feb 10;1373:144-59.

Korostenskaja M, Pardos M, Fujiwara H, Kujala T, Horn P, Rose D, Byars A, Brown D, Seo JH, Wang Y, Vannest J, Xiang J, Degrauw T, Näätänen R, Lee KH. Neuromagnetic evidence of impaired cortical auditory processing in pediatric intractable epilepsy. Epilepsy Res. 2010 Nov;92(1):63-73.

Vannest J, Rasmussen J, Eaton KP, Patel K, Schmithorst V, Karunanayaka P, Plante E, Byars A, Holland S. FMRI activation in language areas correlates with verb generation performance in children. Neuropediatrics. 2010 Oct;41(5):235-9.

Szaflarski JP, Eaton K, Ball AL, Banks C, Vannest J, Allendorfer JB, Page S, Holland SK. Poststroke Aphasia Recovery Assessed With Functional Magnetic Resonance Imaging and a Picture Identification Task. J Stroke Cerebrovasc Dis. 2010 Aug 17.

Karunanayaka P, Schmithorst VJ, Vannest J, Szaflarski JP, Plante E, Holland SK. A group independent component analysis of covert verb generation in children: a functional magnetic resonance imaging study. NeuroImage. 2010 May 15;51(1):472-87.

Vannest J, Karunanayaka PR, Schmithorst VJ, Szaflarski JP, Holland SK. Language networks in children: evidence from functional MRI studies. AJR Am J Roentgenol. 2009 May;192(5):1190-6.

Vannest JJ, Karunanayaka PR, Altaye M, Schmithorst VJ, Plante EM, Eaton KJ, Rasmussen JM, Holland SK. Comparison of fMRI data from passive listening and active-response story processing tasks in children. J Magn Reson Imaging. 2009 Apr;29(4):971-6.

Wang Y, Xiang J, Kotecha R, Vannest J, Liu Y, Rose D, Schapiro M, Degrauw T. Spatial and frequency differences of neuromagnetic activities between the perception of open- and closed-class words. Brain Topogr. 2008 Dec;21(2):75-85.

Liu Y, Xiang J, Wang Y, Vannest JJ, Byars AW, Rose DF. Spatial and frequency differences of neuromagnetic activities in processing concrete and abstract words. Brain Topogr. 2008 Spring;20(3):123-9.

Vannest J, Szaflarski JP, Privitera MD, Schefft BK, Holland SK. Medial temporal fMRI activation reflects memory lateralization and memory performance in patients with epilepsy. Epilepsy Behav. 2008 Apr;12(3):410-8.

Charles V. Vorhees, PhD

513-636-8622

charles.vorhees@cchmc.org

High Res

Charles V. Vorhees, PhD

Professor, UC Department of Pediatrics

Phone: 513-636-8622

Fax: 513-636-3912

Email: charles.vorhees@cchmc.org

Show All

Specialties

Principal areas of investigation are how drugs, genetic mutations, environmental agents, and stressors affect prenatal and neonatal brain development and behavior. The lab is particularly interested in the long-term effects of such perturbations on cognitive development.

Visit the Vorhees-Williams-Skelton Lab.

Biography

Dr. Vorhees came to Cincinnati Children’s in 1976 as a postdoctoral research scholar and was recruited to the faculty in 1978 as assistant professor. He was promoted to associate professor in 1982, tenured in 1984, and promoted to professor in 1988 with primary appointment in pediatrics and joint appointment in environmental health. He is co-director of the Animal Behavior Core and program director of the Teratology Training Program. He is on the graduate faculty of the Graduate Programs in Neuroscience (NS) and Molecular and Developmental Biology (MDB). He is section editor of the journal Neurotoxicology and Teratology and served as editor-in-chief for nine years. He was director of the MDB Graduate Program for six years and served in other leadership positions for 15 years. Dr. Vorhees has also served in leadership positions in the NS Program and is currently a member of the Admissions Committee. Dr. Vorhees has been extramurally funded for 35 years, receiving grants from NIH, NSF, FDA and other agencies. He holds an NIH T32 training grant funded for years 36-40 through 2017. He is a founding member of the Neurobehavioral Teratology Society in 1977 and was elected president in 1984-85 and 2012-13. He is an elected member of Sigma Xi, an Eli Lilly Distinguished Lecturer in 1990, and a Society for Neuroscience Grass Foundation Lecturer in 2002. Dr. Vorhees has served on multiple FDA, NRC, and EPA advisory panels. He has been an NIH grant reviewer on varies committees for more than 26 years. He has also reviewed grants for NSF, VA, EPA; March of Dimes, and other agencies and foundations in the U.S.; and for funding agencies in Israel, Ireland, Great Britain, and New Zealand. His research focuses on brain development and behavior. As of 2013 he has published than more 276 journal articles and book chapters.

Visit the Vorhees Lab Site

Visit the Animal Behavioral Core Site

Education and Training

MA: Neurobiology Program, Vanderbilt University, Nashville, TN, 1973.

PhD: Neurobiology Program, Vanderbilt University, Nashville, TN, 1976.

Publications

View PubMed Publications

Hautman ER, Williams MT, Vorhees CV, Skelton MR. Female mice heterozygous for creatine transporter deficiency have reduced brain creatine, are hypoactive, but show no cognitive deficits. J Inherited Metab Dis. 2013. (In press).

Sun Y, Zamzow M, Ran H, Zhang W, Quinn B, Barnes S, Witte DP, Setchell KDR, Williams MT, Vorhees CV, Grabowski GA. Tissue-specific effects of saposin A and saposin B on glycosphingolipids degradation in mutant mice. Hum Mol Genet. 2013. (In press).

Amos-Kroohs RM, Williams MT, Braun AA, Graham DL, Webb CL, Birtles TS, Greene RM, Vorhees CV, Pisano MM. Neurobehavioral phenotype of C57BL/6J mice prenatally and neonatally exposed to cigarette smoke. Neurotoxicol Teratol. 2013;35, 34-45.

Schaefer TL, Grace CE, Braun AA, Amos-Kroohs RM, Graham DL, Skelton MR, Williams MT, Vorhees CV. Cognitive impairments from developmental exposure to serotonergic drugs: citalopram or MDMA. Int J Neuropsychopharmacol. 2013;16, 1383-94.

Graham DL, Amos-Kroohs RM, Braun AA, Grace CE, Schaefer TL, Skelton MR, Vorhees CV, Williams MT. Neonatal (+)-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists. Int J Neuropsychopharmacol. 2012;16, 377-391.

Vorhees CV, Graham DL, Braun AA, Schaefer TL, Skelton MR, Richtand NM, Williams MT. Prenatal immune challenge in rats: Altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to Poly IC. Synapse. 2012;66(8), 725-737.

Schaefer TL, Braun AA, Amos-Kroohs RM, Williams MT, Ostertag E, Vorhees CV. A new model of Pde4d deficiency: Genetic knock-down of PDE4D enzyme in rats produces an antidepressant phenotype without spatial cognitive effects. Genes Brain Behav. 2012;11(5), 614-622.

Chen Y, Curran CP, Nebert DW, Patel KV, Williams MT, Vorhees CV. Effect of chronic glutathione deficiency on the behavioral phenotype of Gclm(-/-) knockout mice. Neurotoxicol Teratol. 2012;34, 450-457.

Skelton MR, Graham DL, Schaefer TL, Grace CE, Braun AA, Burns LA, Amos-Kroohs RM, Williams MT, Vorhees CV. Distinct periods of developmental sensitive to the effects 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats. Int J Neuropsychopharmacol. 2012;15, 811-824.

Braun AA, Graham DL, Schaefer TL, Vorhees CV, Williams MT. Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats. Neurobiol Learn Mem. 2012;97(4), 402-408.

Grants

Training Grant in Teratology. Principal Investigator. National Institutes of Health. 2007 - 2012.

Selective disruption of hippocampal dentate granule cells in autism: impact of PTEN deletion.Co-Investigator, National Institutes of Health. 2009-2014

Acute neurotoxicity of pyrethroids. Principal Investigator. CAPHRA. 2012-2014.

Prenatal SSRI Exposure and ASD. Principal Investigator. Congressionally Directed Medical Research Program, Department of Defense. 2013-2015.

Latrophilin-3 and ADHD: A new potential mechanism. Principal Investigator. National Institutes of Health. 2013-2015.

Training Grant in Teratology. Principal Investigator. National Institutes of Health. 2012-2017.

Anna Weber Byars, PhD, ABPP-Cn
Pediatric Neuropsychologist

513-636-4222

Kris R. Wesselkamper, MD
Pediatric Neurologist

513-636-4222

kris.wesselkamper@cchmc.org

Brenda Wong, MD, MBBS
Professor of Clinical Pediatrics and Neurology, Director of Comprehensive Neuromuscular Center

513-636-4222

brenda.wong@cchmc.org

High Res

Brenda Wong, Md, MBBS

Professor of Clinical Pediatrics and Neurology, Director of Comprehensive Neuromuscular Center

Associate Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-3980

Email: brenda.wong@cchmc.org

Show All

Specialties

Neuromuscular disorders

Biography

After medical school, Brenda Wong, MD, received training in General Pediatrics and worked as a pediatrician for a few years before doing her three-year Child Neurology fellowship at Children's Hospital Medical Center, Cincinnati.

Dr. Wong also received training in Pediatric Neuromuscular Disorders at Hammersmith Hospital, London with Dr. Victor Dubowitz and Dr. Francesco Muntoni. Dr. Wong's training in EMGs was accomplished with Dr. John Quinlan at Department of Neurology, University of Cincinnati.

Post fellowship training, Dr. Wong was practicing child neurology in private practice prior to joining Children's Hospital Medical Center of Cincinnati in 1999.

Besides general neurology patients, Dr. Wong sees patients with neuromuscular disorders in the Neuromuscular Clinic and provide diagnostic services like EMGs and evaluation for muscle biopsies. Comprehensive management is supported by the Department of Rehabilitative Medicine, Pulmonary Medicine, Pediatric Orthopedics and the Muscular Dystrophy Association.

Education and Training

MD: University of Singapore, 1980.

Residency: University Department of Pediatrics, Singapore, 1981, 1984-85, Royal Hospital for Sick Children, Edinburgh 1985-88.

Fellowship: Child Neurology, Children's Hospital Medical Center, Cincinnati, OH, 1994-97; Neuromuscular Disorders, Hammersmith Hospital, London, 1997.

Certification: Child Neurology, 1998.

Publications

View PubMed Publications

Kim HK, Laor T, Horn PS, Racadio JM, Wong B, Dardzinski BJ. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology. 2010 Jun;255(3):899-908.

Kim HK, Laor T, Horn PS, Wong B. Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment. Korean J Radiol. 2010 May-Jun;11(3):304-11.

Yang Z, Funke BH, Cripe LH, Vick GW 3rd, Mancini-Dinardo D, Peña LS, Kanter RJ, Wong B, Westerfield BH, Varela JJ, Fan Y, Towbin JA, Vatta M. LAMP2 microdeletions in patients with Danon disease. Circ Cardiovasc Genet. 2010 Apr;3(2):129-37.

Henderson RC, Berglund LM, May R, Zemel BS, Grossberg RI, Johnson J, Plotkin H, Stevenson RD, Szalay E, Wong B, Kecskemethy HH, Harcke HT. The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy. J Bone Miner Res. 2010 Mar; 25(3):520-6.

Grants

Steve W. Wu, MD

513-636-4222

High Res

Steve W. Wu, MD

Assistant Professor, UC Department of Pediatrics

Phone: 513-636-4222

Show All

Specialties

Neuroplasticity; movement disorders; transcranial magnetic stimulation; transcranial magnetic stimulation lab

Visit the Gilbert-Wu Lab.

Biography

Dr. Steve Wu is a pediatric neurologist with interests in children with movement disorders. His research interest focuses on movement disorders and neuroplasticity of the brain. Dr. Wu collaborates with Dr. Donald Gilbert in the Transcranial Magnetic Stimulation Lab at Cincinnati Children’s Hospital Medical Center.

Education and Training

BA: University of California, Berkeley CA, 1997.

MD: Vanderbilt University, Nashville TN, 2003.

Residency: Pediatrics and Pediatric Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati OH, 2003-2008.

Fellowship: Pediatric Movement Disorders, Cincinnati Children’s Hospital Medical Center, Cincinnnati OH, 2008-2009.

Publications

Lehman LL, Gilbert DL, Leach JL, Wu SW, Standridge SM. Vertebral Artery Dissection Leading to Stroke Caused by Violent Neck Tics of Tourette Syndrome. Neurology. 2011.

Wu SW, Gilbert DL. Altered neurophysiologic response to intermittent theta burst stimulation in Tourette Syndrome. Brain Stimulation. 2011.

Szaflarski J, Vannest J, Wu SW, DiFrancesco M, Banks C, Gilbert DL. Excitatory repetitive transcranial magnetic stimulation induces improvements in chronic post-stroke aphasia. Med Sci Monit. 2011 Feb;17(3):132-139.

Wu SW, Harris E, Gilbert DL. Tic suppression: the medical model. J Child Adolesc Psychopharmacol. 2010 Aug;20(4):263-276.

Harris E, Wu SW. Children with tic disorders: How to match treatment with symptoms. Current Psychiatry. 2010;9:29-36.

Wu SW, Graham B, Gelfand MJ, Gruppo RE, Dinopolous A, Gilbert DL. Clinical and positron emission tomography findings of chorea associated with primary antiphospholipid antibody syndrome. Mov Disord. 2007 Sep;22(12):1813-1815.

Wu SW, Gilbert DL, Phillips T. Retrospective analysis of electroencephalograms in neonates suspected of having seizures. J Child Neurol. 2007;22:669-670.

Jing Xiang, MD, PhD
Director of MEG Research

513-636-4222

jing.xiang@cchmc.org

High Res

Jing Xiang, MD, PhD

Director of MEG Research

Associate Professor, UC Department of Pediatrics

Phone: 513-636-4222

Fax: 513-636-1888

Email: jing.xiang@cchmc.org

Show All

Specialties

Epilepsy and pre-operative functional mapping

Visit the Xiang Lab.

Education and Training

MD: Postgraduate Medical School, Beijing, China, 1994.

PhD: The Graduate University for Advanced Studies, Okazaki, Japan, 1998.

Publications

View PubMed Publications

Zhang F, Hammer T, Banks HL, Benson C, Xiang J, Fu QJ. Mismatch negativity and adaptation measures of the late auditory evoked potential in cochlear implant users. Hear Res. 2010 Dec 1.

Korostenskaja M, Pardos M, Fujiwara H, Kujala T, Horn P, Rose D, Byars A, Brown D, Seo JH, Wang Y, Vannest J, Xiang J, Degrauw T, Näätänen R, Lee KH. Neuromagnetic evidence of impaired cortical auditory processing in pediatric intractable epilepsy. Epilepsy Res. 2010 Nov;92(1):63-73.

Meng L, Xiang J, Kotecha R, Rose D, Zhao H, Zhao D, Yang J, Degrauw T. White matter abnormalities in children and adolescents with temporal lobe epilepsy. Magn Reson Imaging. 2010 Nov;28(9):1290-8.

Huo X, Wang Y, Kotecha R, Kirtman EG, Fujiwara H, Hemasilpin N, Degrauw T, Rose DF, Xiang J. High Gamma Oscillations of Sensorimotor Cortex During Unilateral Movement in the Developing Brain: a MEG Study. Brain Topogr. 2011 Jan;23(4):375-84.

Wang X, Xiang J, Wang Y, Pardos M, Meng L, Huo X, Korostenskaja M, Powers SW, Kabbouche MA, Hershey AD. Identification of abnormal neuromagnetic signatures in the motor cortex of adolescent migraine. Headache. 2010 Jun;50(6):1005-16.

Chen Y, Xiang J, Kirtman EG, Wang Y, Kotecha R, Liu Y. Neuromagnetic biomarkers of visuocortical development in healthy children. Clin Neurophysiol. 2010 Sep;121(9):1555-62.

Xiang J, Wang Y, Chen Y, Liu Y, Kotecha R, Huo X, Rose DF, Fujiwara H, Hemasilpin N, Lee K, Mangano FT, Jones B, DeGrauw T. Noninvasive localization of epileptogenic zones with ictal high-frequency neuromagnetic signals. J Neurosurg Pediatr. 2010 Jan;5(1):113-22.

Huo X, Xiang J, Wang Y, Kirtman EG, Kotecha R, Fujiwara H, Hemasilpin N, Rose DF, Degrauw T. Gamma oscillations in the primary motor cortex studied with MEG. Brain Dev. 2010 Sep;32(8):619-24.

Xiang J, Liu Y, Wang Y, Kirtman EG, Kotecha R, Chen Y, Huo X, Fujiwara H, Hemasilpin N, Lee K, Mangano FT, Leach J, Jones B, DeGrauw T, Rose D. Frequency and spatial characteristics of high-frequency neuromagnetic signals in childhood epilepsy. Epileptic Disord. 2009 Jun;11(2):113-25.

Xiang J, Liu Y, Wang Y, Kotecha R, Kirtman EG, Chen Y, Huo X, Fujiwara H, Hemasilpin N, DeGrauw T, Rose D. Neuromagnetic correlates of developmental changes in endogenous high-frequency brain oscillations in children: a wavelet-based beamformer study. Brain Res. 2009 Jun 5;1274:28-39.

Quick Links

Quick Links

Quick Links

Quick Links

Quick Links

Neurology / Pediatrics

E-mail this page

Neurology / Pediatrics

Division Director

Andrew D. Hershey, MD, PhD, FAHS

Specialties

Clinical Interests

Research Interests

Biography

Education and Training

Publications

Residency Program Director

Donald L. Gilbert, MD, MS

Specialties

Clinical Interests

Research Interests

Biography

Education and Training

Publications

Faculty

Todd M. Arthur, MD

Specialties

Education and Training

Jim J. Collins, MD, PhD

Specialties

Biography

Education and Training

Publications

David Neal Franz, MD

Specialties

Biography

Education and Training

Publications

Donald L. Gilbert, MD, MS

Specialties

Clinical Interests

Research Interests

Biography

Education and Training

Publications

Tracy A. Glauser, MD

Specialties

Clinical Interests

Research Interests

Biography

Education and Training

Publications

Grants

Barbara E. Hallinan, MD, PhD

Specialties

Education and Training

Publications

Andrew D. Hershey, MD, PhD, FAHS

Specialties

Clinical Interests

Research Interests

Biography

Education and Training

Publications

Katherine D. Holland-Bouley, MD, PhD

Specialties

Education and Training

Publications

Sejal V. Jain, MD

Specialties

Clinical Interests

Research Interests

Biography

Education and Training

Publications

Book Chapters

Grants

Marielle A. Kabbouche, MD

Specialties

Clinical Interests